Topical Antifungal Treatment for Tinea Pedis

NCT01396785 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Pedis

Interventions

DRUG: 33525
DRUG: Placebo

Sponsor

Medicis Global Service Corporation